Your browser doesn't support javascript.
loading
Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis.
Mor, Adam; Mitnick, Hal J; Greene, Jeffry B; Azar, Natalie; Budnah, Reynaldo; Fetto, Joseph.
Affiliation
  • Mor A; Division of Rheumatology, New York University School of Medicine/Hospital for Joint Diseases, 301 East 17th Street, Rm. 1410, New York, NY 10003, USA. mora01@med.nyu.edu
J Clin Rheumatol ; 12(2): 87-9, 2006 Apr.
Article in En | MEDLINE | ID: mdl-16601543
Septic arthritis is a commonly reported complication of rheumatoid arthritis (RA). Tumor necrosis factor alpha (TNF-alpha) plays an important role in host defense against infection. Inhibition of its activity could therefore be anticipated to augment the risk of infection. Both opportunistic and bacterial infections have been described in patients with RA treated with anti-TNF-alpha therapy. We describe a patient who experienced 2 episodes of septic arthritis. Both occurred while the patient was on etanercept. Recurrence developed despite prolonged parenteral antibiotic. To our knowledge, this is the first report of relapsing oligoarticular methicillin-sensitive Staphylococcus aureus septic arthritis despite prolonged antibiotic treatment in a patient receiving etanercept therapy. Our case underscores the advisability of discontinuing TNF-alpha blockade in patients with septic arthritis during prolonged antimicrobial therapy.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Immunoglobulin G / Arthritis, Infectious / Receptors, Tumor Necrosis Factor / Antirheumatic Agents Limits: Aged / Humans / Male Language: En Journal: J Clin Rheumatol Journal subject: FISIOLOGIA / ORTOPEDIA / REUMATOLOGIA Year: 2006 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Immunoglobulin G / Arthritis, Infectious / Receptors, Tumor Necrosis Factor / Antirheumatic Agents Limits: Aged / Humans / Male Language: En Journal: J Clin Rheumatol Journal subject: FISIOLOGIA / ORTOPEDIA / REUMATOLOGIA Year: 2006 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos